ELOX — Eloxx Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Eloxx Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	48.6	56.3	24.7	42.3	19.2
Prepaid Expenses
Total Other Current Assets
Total Current Assets	50.3	57.7	25.9	43.5	20.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.248	1.13	0.554	1.66	0.994
Other Long Term Assets
Total Assets	50.7	58.9	26.5	45.1	21.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.81	11.8	9.84	9.96	23.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.81	22.7	16.2	22.8	31.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	42.9	36.2	10.2	22.4	-10.7
Total Liabilities & Shareholders' Equity	50.7	58.9	26.5	45.1	21.1
Total Common Shares Outstanding